Evidence map›Paper›PMID 26845690›Full record

ArticlePLoS pathogens2016

Genomic Modifiers of Natural Killer Cells, Immune Responsiveness and Lymphoid Tissue Remodeling Together Increase Host Resistance to Viral Infection.

Alyssa Lundgren Gillespie, Jeffrey Teoh, Heather Lee, Jessica Prince, Michael D Stadnisky, Monique Anderson, William Nash, Claudia Rival, Hairong Wei, Awndre Gamache and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Licensing Natural Killers for Antiviral Immunity.Pathogens (Basel, Switzerland) · 2021
    Review
  4. Article
  5. Review
  6. Article
  7. Genome-Wide Exome Analysis ofG3 (Bethesda, Md.) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Alyssa Lundgren GillespieDepartment of Medicine, Division of Nephrology, University of Virginia, Charlottesville, Virginia, United States of America.
Jeffrey TeohBeirne Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, United States of America.
Heather LeeDepartment of Biology, University of Virginia, Charlottesville, Virginia, United States of America.
Jessica PrinceDepartment of Medicine, Division of Nephrology, University of Virginia, Charlottesville, Virginia, United States of America.
Michael D StadniskyBeirne Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, United States of America.
Monique AndersonDepartment of Pathology, University of Virginia, Charlottesville, Virginia, United States of America.
William NashBeirne Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, United States of America.
Claudia RivalBeirne Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, United States of America.
Hairong WeiDepartment of Medicine, Division of Nephrology, University of Virginia, Charlottesville, Virginia, United States of America.
Awndre GamacheBeirne Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, United States of America.
Charles R FarberDepartment of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia, United States of America.
Kenneth TungBeirne Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, United States of America.
Michael G BrownDepartment of Medicine, Division of Nephrology, University of Virginia, Charlottesville, Virginia, United States of America.
University of Virginia · USCarter Center · US

Funding

INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007496 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Michael G. Brown, Coleen A McNamara · 1995 to 2026
$10.2M
Molecular study of mouse viral resistance mechanisms.R01AI050072 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BROWN, MICHAEL G · 2001 to 2021
$7.1M
ZONA PELLUCIDA--IMMUNOPATHOLOGIC STUDYR01AI041236 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI TUNG, KENNETH S.K. · 1996 to 2017
$5.2M
MHC regulation of NK cell mediated virus immunityR01AI082024 · NIAID · UNIVERSITY OF VIRGINIA · PI BROWN, MICHAEL G · 2010 to 2013
$1.5M
Genetic basis of secondary lymphoid organ protection after virus infectionR21AI118269 · NIAID · UNIVERSITY OF VIRGINIA · PI BROWN, MICHAEL G · 2015 to 2016
$430k
NIAID NIH HHS AI050072NIAID NIH HHS AI07046NIAID NIH HHS AI07496NIAID NIH HHS AI082024NIAID NIH HHS AI118269NIAID NIH HHS R01 AI041236NIAID NIH HHS R01 AI050072NIAID NIH HHS R01 AI082024NIAID NIH HHS R21 AI118269NIAID NIH HHS T32 AI007046NIAID NIH HHS T32 AI007496
6 · The paper itself

Abstract

The MHC class I D(k) molecule supplies vital host resistance during murine cytomegalovirus (MCMV) infection. Natural killer (NK) cells expressing the Ly49G2 inhibitory receptor, which specifically binds D(k), are required to control viral spread. The extent of D(k)-dependent host resistance, however, differs significantly amongst related strains of mice, C57L and MA/My. As a result, we predicted that relatively small-effect modifier genetic loci might together shape immune cell features, NK cell reactivity, and the host immune response to MCMV. A robust D(k)-dependent genetic effect, however, has so far hindered attempts to identify additional host resistance factors. Thus, we applied genomic mapping strategies and multicolor flow cytometric analysis of immune cells in naive and virus-infected hosts to identify genetic modifiers of the host immune response to MCMV. We discovered and validated many quantitative trait loci (QTL); these were mapped to at least 19 positions on 16 chromosomes. Intriguingly, one newly discovered non-MHC locus (Cmv5) controlled splenic NK cell accrual, secondary lymphoid organ structure, and lymphoid follicle development during MCMV infection. We infer that Cmv5 aids host resistance to MCMV infection by expanding NK cells needed to preserve and protect essential tissue structural elements, to enhance lymphoid remodeling and to increase viral clearance in spleen.

Indexed as

AnimalsChromosome MappingCytomegalovirus InfectionsFemaleGenes, MHC Class IGenetic LociGenotypeHistocompatibility Antigens Class IHumansImmunity, CellularKiller Cells, NaturalLymphoid TissueMaleMiceMice, Inbred C57BLMuromegalovirusD(kappa) (62-85) peptideHistocompatibility Antigens Class ILy49G2 receptorReceptors, Immunologic

Identifiers

PMID26845690
PMCPMC4742223
OpenAlexW2291122892

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.